Publicaciones en las que colabora con María Isabel Zudaire Ripa (19)

2015

  1. Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

    BMC Genomics, Vol. 16, Núm. 1

2014

  1. Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype

    EMBO Molecular Medicine, Vol. 6, Núm. 4, pp. 539-550

  2. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations

    International Journal of Cancer, Vol. 135, Núm. 11, pp. 2516-2527

  3. TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC

    Molecular Cancer Research, Vol. 12, Núm. 5, pp. 660-669

2013

  1. Identificación de marcadores genómicos con valor pronóstico en pacientes diagnosticados de carcinoma de pulmón en estadio temprano mediante microarrays de single nucleotide polymorphisms (SNPs)

    Anales del sistema sanitario de Navarra, Vol. 36, Núm. 1, pp. 167-169

2012

  1. Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung

    Journal of Clinical Oncology, Vol. 30, Núm. 10, pp. 1129-1136

2008

  1. Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates

    Histology and Histopathology, Vol. 23, Núm. 1, pp. 33-40

2006

  1. Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features

    Cancer Epidemiology Biomarkers and Prevention, Vol. 15, Núm. 2, pp. 373-380

2005

  1. Erratum: NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2 (Cancer Genetics and Cytogenetics (2005) 157 (151-6))

    Cancer Genetics and Cytogenetics

  2. FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome

    Human Genetics, Vol. 116, Núm. 6, pp. 476-485

  3. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2

    Cancer Genetics and Cytogenetics, Vol. 157, Núm. 2, pp. 151-156

2004

  1. FISH-Blood and Bone Marrow

    Encyclopedia of Diagnostic Genomics and Proteomics (Marcel Dekker), pp. 461 - 467

  2. αCP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant αCP-4a, is underexpressed in lung cancer

    Cancer Research, Vol. 64, Núm. 12, pp. 4171-4179

2002

  1. Desarrollo de la técnica de FICTION como nueva herramienta para el diagnóstico precoz de cáncer de pulmón

    Anales del sistema sanitario de Navarra, Vol. 25, Núm. 3, pp. 305-315

  2. Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas

    Histopathology, Vol. 40, Núm. 6, pp. 547-555

2001

  1. Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL

    Cancer Genetics and Cytogenetics, Vol. 130, Núm. 1, pp. 8-13

  2. Identificación de nuevos marcadores citogenéticos con valor pronóstico en cáncer de mama

    Anales del sistema sanitario de Navarra, Vol. 24, Núm. 1, pp. 25-37

2000

  1. Contribucion de la citogenetica molecular al diagnostico y pronostico del cancer de mama

    Contribucion de la citogenetica molecular al diagnostico y pronostico del cancer de mama

  2. Técnicas de citogenética molecular: aplicaciones en el diagnóstico e investigación del cáncer

    Revista Española de Patología, Vol. 33, Núm. 4, pp. 357 - 369